Summit Therapeutics Inc.

SMMT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001599298

SEC filings (opens in a new tab)

No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Summit Therapeutics Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of SMMT: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	103	2	121	+20
Shares	49.6M	127.6K	72.2M	+22.7M (+46.0%)
Value	$205.5M	$527.9K	$563.0M	+$358.1M (+174.7%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (40)

Institutions that held Summit Therapeutics Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to SMMT in Q2 2024
Institution	Shares	Value	% of portfolio
Baker Bros. Advisors LP	23,222,222	$181.1M	2.31%
Millennium Management LLC	1,942,858	$15.2M	0.01%
Balyasny Asset Management LLC	1,010,157	$7.88M	0.02%
Anson Funds Management LP	941,908	$7.35M	1.11%
First Trust Advisors LP	788,067	$6.15M	0.01%
QVT Financial LP	575,705	$4.49M	0.42%
TD Asset Management Inc	266,800	$2.08M	0.00%
Arrowstreet Capital, Limited Partnership	141,680	$1.10M	0.00%
Voloridge Investment Management, LLC	140,577	$1.10M	0.00%
Pinpoint Asset Management Ltd	120,746	$941.8K	0.14%
Simplex Trading, LLC	114,647	$894.0K	0.03%
Hudson Bay Capital Management LP	75,000	$585.0K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	64,818	$506.0K	0.00%
Handelsbanken Fonder AB	63,900	$498.0K	0.00%
AQR Capital Management LLC	62,114	$484.5K	0.00%
Corebridge Financial, Inc.	47,097	$367.4K	0.00%
Omers Administration Corp	35,500	$276.9K	0.00%
State Board of Administration of Florida Retirement System	33,070	$257.9K	0.00%
Brevan Howard Capital Management LP	31,214	$243.5K	0.02%
D. E. Shaw & Co., Inc.	29,700	$231.7K	0.00%
Centiva Capital, LP	29,225	$228.0K	0.01%
Paloma Partners Management Co	28,400	$221.5K	0.02%
Schonfeld Strategic Advisors LLC	21,919	$171.0K	0.00%
Allianz Asset Management GmbH	19,953	$155.6K	0.00%
CIBC Asset Management Inc	19,705	$153.7K	0.00%
Gotham Asset Management, LLC	19,500	$152.1K	0.00%
Boston Private Wealth LLC	17,150	$133.8K	0.00%
Bayesian Capital Management, LP	16,499	$128.7K	0.01%
Fullcircle Wealth LLC	12,209	$121.8K	0.06%
XTX Topco Ltd	15,500	$120.9K	0.01%
Change Path, LLC	11,600	$90.0K	0.00%
Quinn Opportunity Partners LLC	11,000	$85.8K	0.01%
Creative Planning	10,782	$84.1K	0.00%
Wolverine Trading, LLC	10,580	$82.5K	0.00%
Catalyst Funds Management Pty Ltd	6,900	$53.8K	0.01%
Macquarie Group Ltd	1,274	$9.94K	0.00%
SRS Capital Advisors, Inc.	1,019	$7.95K	0.00%
Twin Tree Management, LP	471	$3.67K	0.00%
The PNC Financial Services Group, Inc.	45	$351	0.00%
Allworth Financial LP	22	$194	0.00%

Sold out (20)

Institutions that held Summit Therapeutics Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of SMMT in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Bank of Montreal	589,566	$2.72M
Steward Partners Investment Advisory, LLC	606,500	$2.51M
Alps Advisors Inc	494,924	$2.05M
Swiss National Bank	275,000	$1.14M
UBS Asset Management Americas Inc	114,592	$474.4K
State of Wisconsin Investment Board	102,394	$423.9K
Janus Henderson Group PLC	76,590	$315.9K
American International Group, Inc.	57,108	$236.4K
Arizona State Retirement System	38,522	$159.5K
Boothbay Fund Management, LLC	35,000	$144.9K
Teacher Retirement System of Texas	31,203	$129.0K
Group One Trading, L.P.	30,019	$124.3K
Oxford Asset Management LLP	27,080	$112.1K
EntryPoint Capital, LLC	24,186	$100.1K
Two Sigma Investments, LP	23,579	$97.6K
Jump Financial, LLC	22,462	$93.0K
Virtu Financial LLC	20,372	$84.0K
Graham Capital Management, L.P.	18,961	$78.5K
Metropolitan Life Insurance Co	6,561	$27.2K
Citadel Advisors LLC	5	$21

Not filed for Q2 2024 yet (2)

Institutions that held Summit Therapeutics Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SMMT in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	111,078	$459.9K
Cutler Group LP	16,500	$68.0K